NON-SMALL CELL LUNG CANCER STAGE IV
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE IV explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE IV trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for patients with rare brain lining cancer spread
Disease control OngoingThis early-phase study tests a new way to give immunotherapy drugs (nivolumab and ipilimumab) for patients with lung cancer or melanoma that has spread to the lining of the brain and spinal cord (leptomeningeal metastases). The drugs are given both directly into the spinal fluid …
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IV
Phase: PHASE1 • Sponsor: University of Zurich • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
New biosimilar aims to match keytruda for lung cancer treatment
Disease control OngoingThis study tests whether SB27, a biosimilar drug, works as well as Keytruda in people with advanced non-squamous non-small cell lung cancer. About 555 adults who have not had prior treatment for metastatic disease will receive either SB27 or Keytruda along with chemotherapy every…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IV
Phase: PHASE3 • Sponsor: Samsung Bioepis Co., Ltd. • Aim: Disease control
Last updated Jun 08, 2026 13:03 UTC